6 research outputs found
Hydroxyapatite Crystal Formation in the Presence of Polysaccharide
Natural
polysaccharides play an important role in the formation
of nanohydroxyapatite (nHA) crystals in biological systems. In this
study, we synthesized nHA crystals in the presence of four polysaccharides,
i.e., pectin, carrageenan, chitosan, and amylose, referred as PeHA,
CaHA, CsHA, and AmHA, respectively. X-ray diffraction, Fourier transform
infrared spectroscopy, transmission electron microscopy, scanning
electron microscope, and thermogravimetric analysis were used to investigate
the formation of nHA crystals. The shape of prepared nHA crystals
is needle/rod-like in all cases, whereas the size increases in the
order of PeHA, CaHA, CsHA, and AmHA. The presence of polysaccharides
induces the heterogeneous nucleation of nHA and further modulates
the crystal growth. Our data suggest that the interaction intensity
between nHA and polysaccharides is in the decreasing order of PeHA,
CaHA, CsHA, and AmHA, resulting in the smallest nHA crystals with
pectin. It is also demonstrated that a high polysaccharide concentration
and short reaction time are adverse to nHA crystals, especially for
the polysaccharides with carboxyl groups. This study can provide insight
into the effects of polysaccharides with different chemical functional
groups (−COOH, −OSO<sub>3</sub>H, −NH<sub>2</sub>, −OH) on the formation of nHA crystals
A Biomimetic Poly(vinyl alcohol)–Carrageenan Composite Scaffold with Oriented Microarchitecture
In
general, the design of a scaffold should imitate certain advantageous
properties of native extracellular matrix (ECM) to operate as a temporary
ECM for cells. From this perspective, a biomimetic scaffold was prepared
using poly(vinyl alcohol) and carrageenan in which axially oriented
pore structure can be formed through a facile unidirectional freeze–thaw
method. We examined the feasibility of this oriented scaffold, which
has better physicochemical properties than a non-oriented scaffold
fabricated by the conventional method. The microenvironment of this
oriented scaffold could imitate biochemical and physical cues of natural
cartilage ECM for guiding spatial organization and proliferation of
cells in vitro, indicating its potential in cartilage repair strategy.
Furthermore, the biocompatibility of the scaffold in vivo was demonstrated
in a subcutaneous rat model, which revealed uniform infiltration and
survival of newly formed tissue into the oriented scaffold after 4
weeks with only a minimal inflammatory response being observed over
the course of the experiments. These results together indicated that
the present biomimetic scaffold with oriented microarchitecture could
be a promising candidate for cartilage tissue engineering
Injectable Fullerenol/Alginate Hydrogel for Suppression of Oxidative Stress Damage in Brown Adipose-Derived Stem Cells and Cardiac Repair
Stem
cell implantation strategy has exhibited potential to treat
the myocardial infarction (MI), however, the low retention and survival
limit their applications due to the reactive oxygen species (ROS)
microenvironment after MI. In this study, the fullerenol nanoparticles
are introduced into alginate hydrogel to create an injectable cell
delivery vehicle with antioxidant activity. Results suggest that the
prepared hydrogels exhibit excellent injectable and mechanical strength.
In addition, the fullerenol/alginate hydrogel can effectively scavenge
the superoxide anion and hydroxyl radicals. Based on these results,
the biological behaviors of brown adipose-derived stem cells (BADSCs)
seeded in fullerenol/alginate hydrogel were investigated in the presence
of H<sub>2</sub>O<sub>2</sub>. Results suggest that the fullerenol/alginate
hydrogels have no cytotoxicity effects on BADSCs. Moreover, they can
suppress the oxidative stress damage of BADSCs and improve their survival
capacity under ROS microenvironment via activating the ERK and p38
pathways while inhibiting JNK pathway. Further, the addition of fullerenol
can improve the cardiomyogenic differentiation of BADSCs even under
ROS microenvironment. To assess its therapeutic effects <i>in
vivo</i>, the fullerenol/alginate hydrogel loaded with BADSCs
were implanted in the MI area in rats. Results suggest that the fullerenol/alginate
hydrogel can effectively decrease ROS level in MI zone, improve the
retention and survival of implanted BADSCs, and induce angiogenesis,
which in turn promote cardiac functional recovery. Therefore, the
fullerenol/alginate hydrogel can act as injectable cell delivery vehicles
for cardiac repair
RoY Peptide-Modified Chitosan-Based Hydrogel to Improve Angiogenesis and Cardiac Repair under Hypoxia
Myocardial infarction (MI) still
represents the “Number One Killer” in the world. The
lack of functional vasculature of the infracted myocardium under hypoxia
is one of the main problems for cardiac repair. In this study, a thermosensitive
chitosan chloride-RoY (CSCl-RoY) hydrogel was developed to improve
angiogenesis under hypoxia after MI. First, RoY peptides were conjugated
onto the CSCl chain via amide linkages, and our data show that the
conjugation of RoY peptide to CSCl does not interfere with the temperature
sensitivity. Then, the effect of CSCl-RoY hydrogels on vascularization
in vitro under hypoxia was investigated using human umbilical vein
endothelial cells (HUVECs). Results show that CSCl-RoY hydrogels can
promote the survival, proliferation, migration and tube formation
of HUVECs under hypoxia compared with CSCl hydrogel. Further investigations
suggest that CSCl-RoY hydrogels can modulate the expression of membrane
surface GRP78 receptor of HUVECs under hypoxia and then activate Akt
and ERK1/2 signaling pathways related to cell survival/proliferation,
thereby enhancing angiogenic activity of HUVECs under hypoxia. To
assess its therapeutic properties in vivo, a MI model was induced
in rats by the left anterior descending artery ligation. CSCl or CSCl-RoY
hydrogels were injected into the border of infracted hearts. The results
demonstrate that the introduction of RoY peptide can not only improve
angiogenesis at MI region but also improve the cardiac functions.
Overall, we conclude that the CSCl-RoY may represent an ideal scaffold
material for injectable cardiac tissue engineering
Zwitterionic-Modified Starch-Based Stealth Micelles for Prolonging Circulation Time and Reducing Macrophage Response
Over the last few decades, nanoparticles
have been emerging as
useful means to improve the therapeutic efficacy of drug delivery
and medical diagnoses. However, the heterogeneity and complexity of
blood as a medium is a fundamental problem; large amounts of protein
can be adsorbed onto the surface of nanoparticles and cause their
rapid clearance before reaching their target sites, resulting in the
failure of drug delivery. To overcome this challenge, we present a
rationally designed starch derivative (SB-ST-OC) with both a superhydrophilic
moiety of zwitterionic sulfobetaine (SB) and a hydrophobic segment
of octane (OC) as functional groups, which can self-assemble into
“stealth” micelles (SSO micelles). The superhydrophilic
SB kept the micelles stable against aggregation in complex media and
imbued them with “stealth” properties, eventually extending
their circulation time in blood. In stability and hemolysis tests
the SSO micelles showed excellent protein resistance properties and
hemocompatibility. Moreover, a phagocytosis test and cytokine secretion
assay confirmed that the SSO micelles had less potential to trigger
the activation of macrophages and were more suitable as a drug delivery
candidate <i>in vivo</i>. On the basis of these results,
doxorubicin (DOX), a hydrophobic drug, was used to investigate the
potential application of this novel starch derivative <i>in vivo</i>. The results of the pharmacokinetic study showed that the values
of the plasma area under the concentration curve (AUC) and elimination
half-life (<i>T</i><sub>1/2</sub>) of the SSO micelles were
higher than those of micelles without SB modifications. In conclusion,
the combination of excellent protein resistance, lower macrophage
activation, and longer circulation time <i>in vivo</i> makes
this synthesized novel starch derivative a promising candidate as
a hydrophobic drug carrier for long-term circulation <i>in vivo.</i